FBRX
Forte Biosciences Inc
77.00$
+0.0%
vs. previous close
Closing price · As of: Aug 28, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Forte Biosciences Inc (FBRX) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 08/27/2026 | Current report (8-K) | Forte Biosciences, Inc. (FBRX): Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Material Modifications to Rights of Security Holders; Changes in Control of Registrant; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Financ | View report ↗ |
| 08/11/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 07/28/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 07/27/2026 | Current report (8-K) | Forte Biosciences, Inc. (FBRX): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 07/09/2026 | Current report (8-K) | Forte Biosciences, Inc. (FBRX): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.